Skip to main page content
Skip to search
Skip to topics menu
Skip to common links
HHS
U.S. Department of Health and Human Services
U.S. Food and Drug Administration
A to Z Index
Follow FDA
En Español
Search FDA
Submit search
Popular Content
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Home
Import Program
Import Alerts
Industry Categories
Import Alert for Industry Pharm Necess & Ctnr For Drug/Bio
Share
Tweet
Linkedin
Pin it
More sharing options
Linkedin
Pin it
Email
Print
Pharm Necess & Ctnr For Drug/Bio
DWPE = Detain without physical examination
Import Alert Number
Import Alert Type
Publish Date
Import Alert Name
53-06
DWPE
04/25/2024
"Detention Without Physical Examination Of Cosmetics That are Adulterated and/or Misbranded Due to Color Additive Violations"
54-16
DWPE
03/12/2024
"DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS THAT ARE MARKETED AS FOODS, INCLUDING PRODUCTS MARKETED AS DIETARY SUPPLEMENTS, THAT CONTAIN AN ACTIVE PHARMACEUTICAL INGREDIENT"
55-03
DWPE
01/18/2024
DETENTION WITHOUT PHYSICAL EXAMINATION OF DIFFERENT FORMS OF HEPARIN AND HEPARIN-RELATED PRODUCTS
55-05
DWPE
01/18/2024
"Detention Without Physical Examination Of Finished Dosage Form Drug Products, Active Pharmaceutical Ingredients, and Inactive Ingredients for Potentially Hazardous Microbiological Contamination"
66-40
DWPE
04/15/2024
"Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"
66-41
DWPE
04/24/2024
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
66-57
DWPE
11/06/2023
"Detention Without Physical Examination of Foreign Manufactured Unapproved Prescription Drugs Distributed to Individuals in the U.S."
66-66
DWPE
12/26/2023
"APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
66-76
DWPE
05/26/2022
"Detention Without Physical Examination of Drugs or Active Pharmaceutical Ingredients From Facilities That Have Not Submitted Self-Identifying Information or Paid Facility or Program Fees Required Under GDUFA "
66-78
DWPE
09/11/2023
"Detention Without Physical Examination of Drugs, Based Upon Analytic Test Results"
66-79
DWPE
04/12/2024
"Detention Without Physical Examination of Drugs From Foreign Establishments Refusing FDA Inspection"
68-19
DWPE
03/26/2024
"DETENTION WITHOUT PHYSICAL EXAMINATION OF UNAPPROVED FINISHED NEW ANIMAL DRUGS"
99-32
DWPE
03/15/2024
"DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS FROM FOREIGN ESTABLISHMENTS REFUSING FDA INSPECTION"
99-34
DWPE
02/02/2024
DETENTION WITHOUT PHYSICAL EXAMINATION OF DRUGS OR MEDICAL DEVICES FROM FIRMS WITHOUT A VALID DRUG OR MEDICAL DEVICE REGISTRATION AND/OR LISTING
99-39
DWPE
04/25/2024
Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
Popular Content
Home
Latest Recalls
Report an Adverse Event
MedWatch Safety Alerts
News Releases
Consumer Updates
About FDA
Contact FDA
Browse by Product Area
Product Areas
back
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products